Zacks Investment Management Amgen Inc Transaction History

Zacks Investment Management

$11.4 Billion
Q3 2024

A detailed history of Zacks Investment Management transactions in Amgen Inc stock. As of the latest transaction made, Zacks Investment Management holds 98,619 shares of AMGN stock, worth $27.4 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

98,619

Holding current value

$27.4 Million

% of portfolio

0.28%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $30.5 Million - $33.3 Million	98,619 New	98,619 $31.8 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $1.29 Million - $1.55 Million	4,784 Added 6.01%	84,438 $24 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $124,270 - $140,191	486 Added 0.61%	79,654 $22.9 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $202,688 - $251,643	927 Added 1.18%	79,168 $21.3 Million
Q2 2023 Aug 15, 2023	BUY	$214.27 - $253.37 $1.73 Million - $2.05 Million	8,097 Added 11.54%	78,241 $17.4 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $1.53 Million - $1.8 Million	-7,122 Reduced 9.22%	70,144 $15.6 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $3.68 Million - $4.49 Million	-16,302 Reduced 17.42%	77,266 $18.7 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $837,104 - $1.06 Million	3,655 Added 4.07%	93,568 $24.6 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $285,962 - $322,513	1,274 Added 1.44%	89,913 $20.3 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $4.64 Million - $5.16 Million	20,107 Added 29.34%	88,639 $21.6 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $661,099 - $731,348	3,015 Added 4.6%	68,532 $16.6 Million
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $218,768 - $250,360	1,100 Added 1.71%	65,517 $14.7 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $66,865 - $78,340	315 Added 0.49%	64,417 $13.7 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $196,907 - $218,455	-843 Reduced 1.3%	64,102 $15.6 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $35.7 Million - $41.6 Million	-161,000 Reduced 71.26%	64,945 $16.2 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $3.89 Million - $4.63 Million	-17,955 Reduced 7.36%	225,945 $51.9 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $4.37 Million - $4.86 Million	-18,613 Reduced 7.09%	243,900 $62 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $521,229 - $639,619	2,635 Added 1.01%	262,513 $61.9 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $478,380 - $634,462	-2,625 Reduced 1.0%	259,878 $52.7 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $1.67 Million - $2.15 Million	8,828 Added 3.48%	262,503 $63.3 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $766,432 - $918,345	4,402 Added 1.77%	253,675 $49.1 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $427,252 - $500,835	2,563 Added 1.04%	249,273 $45.9 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $5.97 Million - $6.73 Million	-33,006 Reduced 11.8%	246,710 $46.9 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $269,562 - $314,665	-1,511 Reduced 0.54%	279,716 $54.5 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $682,237 - $769,132	3,682 Added 1.33%	281,227 $58.3 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $363,981 - $408,829	2,192 Added 0.8%	277,545 $51.2 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $322,086 - $376,398	1,901 Added 0.7%	275,353 $46.9 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $771,876 - $862,422	4,573 Added 1.7%	273,452 $47.6 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $45 Million - $51.4 Million	268,879	268,879 $50.1 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Zacks Investment Management with notifications on news.

Account

Zacks Investment Management Amgen Inc Transaction History